Safety and effectiveness of mogamulizumab in relapsed or refractory adult T-cell leukemia-lymphoma.

Kenji IshitsukaSatoshi YurimotoYukie TsujiManabu IwabuchiTakeshi TakahashiKensei Tobinai

Published in: European journal of haematology (2019)

This postmarketing surveillance confirmed the safety and effectiveness of mogamulizumab for the treatment of patients with r/r ATL, including elderly patients, in clinical practice.

Keyphrases

clinical practice
acute myeloid leukemia
randomized controlled trial
diffuse large b cell lymphoma
systematic review
acute lymphoblastic leukemia
public health
young adults